The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations (Q34152778)

31 July 2017

title

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations (English)

1 reference

31 July 2017

0 references

0 references

1

Gert Van Assche

0 references

Séverine Vermeire

24

object named as

Séverine Vermeire

0 references

Geert D'Haens

13

object named as

Geert D'Haens

0 references

Axel Dignass

2

object named as

Axel Dignass

1 reference

31 July 2017

20

1 reference

31 July 2017

9

Iris Dotan

1 reference

31 July 2017

3

Walter Reinisch

1 reference

31 July 2017

22

Christian Mottet

1 reference

31 July 2017

author name string

C Janneke van der Woude

4

1 reference

31 July 2017

Andreas Sturm

5

1 reference

31 July 2017

Martine De Vos

6

1 reference

31 July 2017

Mario Guslandi

7

1 reference

31 July 2017

Bas Oldenburg

8

1 reference

31 July 2017

Philippe Marteau

10

1 reference

31 July 2017

Alessandro Ardizzone

11

1 reference

31 July 2017

Daniel C Baumgart

12

1 reference

31 July 2017

Paolo Gionchetti

14

1 reference

31 July 2017

Francisco Portela

15

1 reference

31 July 2017

Boris Vucelic

16

1 reference

31 July 2017

Johan Söderholm

17

1 reference

31 July 2017

Johanna Escher

18

1 reference

31 July 2017

Sibylle Koletzko

19

1 reference

31 July 2017

Milan Lukas

21

1 reference

31 July 2017

Herbert Tilg

23

1 reference

31 July 2017

Frank Carbonnel

25

1 reference

31 July 2017

Andrew Cole

26

1 reference

31 July 2017

Gottfried Novacek

27

1 reference

31 July 2017

Max Reinshagen

28

1 reference

31 July 2017

Epameinondas Tsianos

29

1 reference

31 July 2017

Klaus Herrlinger

30

1 reference

31 July 2017

Bas Oldenburg

31

1 reference

31 July 2017

Yoram Bouhnik

32

1 reference

31 July 2017

Ralf Kiesslich

33

1 reference

31 July 2017

Eduard Stange

34

1 reference

31 July 2017

Simon Travis

35

1 reference

31 July 2017

James Lindsay

36

1 reference

31 July 2017

European Crohn's and Colitis Organisation (ECCO)

37

1 reference

31 July 2017

publication date

21 December 2009

1 reference

Journal of Crohn's and Colitis

31 July 2017

published in

1 reference

31 July 2017

volume

4

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

63-101

1 reference

Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Recurrence patterns after first resection for stricturing or penetrating Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Recovery rates and functional results after repair for rectovaginal fistula in Crohn's disease: a comparison of different techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Safety and efficacy of strictureplasty for Crohn's disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

MRI evaluation of Crohn's disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Modern imaging of Crohn's disease using bowel ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Do patients consider postoperative maintenance therapy for Crohn's disease worthwhile?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Mesalamine and relapse prevention in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Current status and influence of operation on perianal Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Endosonographic evidence of persistence of Crohn's disease-associated fistulas after infliximab treatment, irrespective of clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Assessment and classification of fistula-in-ano in patients with Crohn's disease by hydrogen peroxide enhanced transanal ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Clinical examination, endosonography, and MR imaging in preoperative assessment of fistula in ano: comparison with outcome-based reference standard.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Imaging of fistula in ano.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

A classification of fistula-in-ano

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Infliximab maintenance therapy for fistulizing Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Adalimumab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Certolizumab pegol for the treatment of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

AGA technical review on perianal Crohn’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Gracilis muscle interposition for the treatment of rectourethral, rectovaginal, and pouch-vaginal fistulas: results in 53 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Gracilis transposition for repair of recurrent anovaginal and rectovaginal fistulas in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Incidence of inflammatory bowel disease in Finnish children, 1987-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Inflammatory bowel disease in children and adolescents in Italy: data from the pediatric national IBD register (1996-2003).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

IBD and IBD mimicking enterocolitis in children younger than 2 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Gastrointestinal manifestations of chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Natural history of pediatric Crohn's disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Presenting features of inflammatory bowel disease in Great Britain and Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Guidelines for the management of growth failure in childhood inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Long-term psychosocial outcomes reported by children and adolescents with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Age and Family History at Presentation of Pediatric Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Laboratory values for children with newly diagnosed inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Review article: biological activity markers in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Histological diagnosis of chronic inflammatory bowel disease in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Colonoscopy under general anesthesia in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Complicated endoscopic pediatric procedures using deep sedation and general anesthesia are safe in the endoscopy suite

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Barium studies and ileoscopy compared in children with suspected Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Crohn's disease: factors associated with exposure to high levels of diagnostic radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Radiation doses from small-bowel follow-through and abdomen/pelvis MDCT in pediatric Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Gadolinium-enhanced magnetic resonance imaging: a useful radiological tool in diagnosing pediatric IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Magnetic resonance imaging in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Pelvic MRI in children with Crohn disease and suspected perianal involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Inflammatory bowel disease: imaging of the pediatric patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Diagnosis of small bowel Crohn's disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

A Meta-Analysis of the Yield of Capsule Endoscopy Compared to Other Diagnostic Modalities in Patients with Non-Stricturing Small Bowel Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Wireless capsule endoscopy in the pediatric age group: experience and complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

The feasibility of wireless capsule endoscopy in detecting small intestinal pathology in children under the age of 8 years: a multicentre European study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Meta-analysis: enteral nutrition in active Crohn's disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Growth retardation in pediatric Crohn's disease: pathogenesis and interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Systematic review: nutritional therapy in paediatric Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Cochrane Database of Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Circulating glucocorticoid bioactivity during peroral glucocorticoid treatment in children and adolescents with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Evaluation of oral budesonide for treatment of mild and moderate exacerbations of Crohn's disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

A comparison of budesonide and prednisone for the treatment of active pediatric Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Role of methotrexate in the management of Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Use of infliximab in the treatment of Crohn's disease in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Use of infliximab in pediatric patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (remicade) in severe pediatric crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Infliximab dependency in pediatric Crohn's disease: long-term follow-up of an unselected cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Human antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Acceleration of linear growth following intestinal resection for Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Factors influencing postoperative recurrence of Crohn's disease in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Postoperative outcome of Crohn's disease in 30 children

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Supplementary enteral nutrition maintains remission in paediatric Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Bone mineral density and nutritional status in children with chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Effect of Calcium and Vitamin D Supplementation on Bone Mineral Density in Children With Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Variations in initial assessment and management of inflammatory bowel disease across Great Britain and Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Pregnancy, delivery, and pouch function after ileal pouch-anal anastomosis for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Social and sexual function following ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Male infertility due to sulphasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Incidence of sulphasalazine-induced male infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Reversible male infertility due to sulphasalazine: studies in man and rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Azathioprine treatment and male fertility in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Infliximab and semen quality in men with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

A meta-analysis on the influence of inflammatory bowel disease on pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Inflammatory bowel disease: a controlled study of late pregnancy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Inflammatory bowel disease in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Surgical resections in parous patients with distal ileal and colonic Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Pregnancy delivery and pouch function after ileal pouch-anal anastomosis for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Vaginal delivery after ileal pouch-anal anastomosis: a word of caution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Effect of vaginal delivery on long-term pouch function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Mode of delivery and risk of fecal incontinence in women with or without inflammatory bowel disease: questionnaire survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Sulphasalazine treatment during breast feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Placental and mammary transfer of sulphasalazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Augmentin treatment during pregnancy and the prevalence of congenital abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Inflammatory bowel disease: management issues during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Budesonide induction and maintenance therapy for Crohn's disease during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Effects of immunosuppressive drugs during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Children of renal transplant recipient mothers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Pregnancy outcome following cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

The genetic toxicology of 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Azathioprine, mercaptopurine and birth outcome: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Complications of pregnancy and child development after cessation of treatment with 6-mercaptopurine for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Adalimumab use in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Thalidomide: current and potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Recognition of thalidomide defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Treatment of intractable hyperemesis gravidarum by ondansetron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Gastrointestinal motility disorders during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Transfer of drugs and other chemicals into human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Quality of life in patients with established inflammatory bowel disease: a UK general practice survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Depression and anxiety in people with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Health status and health care use in persons with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Influence of inflammatory bowel disease on different dimensions of quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

The quality of life in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Psychiatric illness in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Relapse-precipitating life events and feelings in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Predicting relapse in Crohn's disease: a biopsychosocial model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Personality profile and affective state of patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Psychiatric predictors of noncompliance in inflammatory bowel disease: psychiatry and compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Psychosocial correlates of patient-physician discordance in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Providing disease-related information worsens health-related quality of life in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

A group-based patient education programme for high-anxiety patients with Crohn disease or ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Assessing the demand for psychological care in chronic diseases: development and validation of a questionnaire based on the example of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Evaluation of a psychological treatment for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Effect of psychotherapy and relaxation on the psychosocial and somatic course of Crohn's disease: main results of the German Prospective Multicenter Psychotherapy Treatment study on Crohn's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Supportive-expressive group psychotherapy for persons with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Muscoloskeletal manifestations in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

An assessment tool for predicting fracture risk in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Important cutaneous manifestations of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Skin ulcers misdiagnosed as pyoderma gangrenosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Diagnosis and treatment of pyoderma gangrenosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Ocular manifestations of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

The medical management of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Hospitalization-based major comorbidity of inflammatory bowel disease in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Inflammation and coagulation in inflammatory bowel disease: The clot thickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Use of unlicensed and off-label medications in paediatric gastroenterology with a review of the commonly used formularies in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Review article: complementary and alternative therapies for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Therapy of active Crohn disease with Boswellia serrata extract H 15

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Acupuncture and Moxibustion in the Treatment of Active Crohn’s Disease: A Randomized Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Infliximab prevents Crohn's disease recurrence after ileal resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Local injection of Infliximab for the treatment of perianal Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Inflammation Is The Main Determinant of Low Bone Mineral Density in Pediatric Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: A multicenter, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Extraintestinal Manifestations of Crohn’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Increased risk of preterm birth for women with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

Vertebral Fractures and Role of Low Bone Mineral Density in Crohn’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2009.09.009

10.1016/J.CROHNS.2009.09.009

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference